Assessment of adherence with oral anticancer agents in oncology clinical trials: A systematic review

Conclusion This systematic review demonstrates adherence reporting in clinical trials of oral anticancer agents is infrequent. When reported, adherence was not associated with overall study quality or other study characteristics. Given the potential effects of non-adherence on study power and validity, adherence reporting should be encouraged in oncology and hematology clinical trials.
Source: Journal of Oncology Pharmacy Practice - Category: Cancer & Oncology Authors: Tags: Review Articles Source Type: research